Logo image
The possible future roles for iPSC-Derived therapy for autoimmune diseases
Journal article   Peer reviewed

The possible future roles for iPSC-Derived therapy for autoimmune diseases

M. Hew, K. O'Connor, M. Edel and M. Lucas
Journal of Clinical Medicine, Vol.4(6), pp.1193-1206
2015
url
Free to Read *No subscription requiredView

Abstract

The ability to generate inducible pluripotent stem cells (iPSCs) and the potential for their use in treatment of human disease is of immense interest. Autoimmune diseases, with their limited treatment choices are a potential target for the clinical application of stem cell and iPSC technology. IPSCs provide three potential ways of treating autoimmune disease; (i) providing pure replacement of lost cells (immuno-reconstitution); (ii) through immune-modulation of the disease process in vivo; and (iii) for the purposes of disease modeling in vitro. In this review, we will use examples of systemic, system-specific and organ-specific autoimmunity to explore the potential applications of iPSCs for treatment of autoimmune diseases and review the evidence of iPSC technology in auto-immunity to date.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.102 Stem Cell Research
1.102.622 Pluripotent Stem Cells
Web Of Science research areas
Immunology
ESI research areas
Clinical Medicine
Logo image